Jubilant Organosys Q1 net dips 50% to Rs 63 cr

Image
Press Trust of India New Delhi
Last Updated : Jan 20 2013 | 1:04 AM IST

Pharmaceutical firm Jubilant Organosys today reported 50.14 per cent decline in consolidated net profit at Rs 62.73 crore for the quarter ended June 30, as compared with the same period a year ago.

The company had posted a net profit of Rs 125.82 crore in the first quarter last fiscal.

Net sales during the quarter stood at Rs 981.51 crore as against Rs 896.36 crore in the comparable period last fiscal, up 9.49 per cent, Jubilant Organosys said in a statement.

During the quarter, the company incurred a loss of Rs 20.8 crore, which included a loss of Rs 3.8 crore on mark to market on interest rates swap and amortisation of unrealised loss Rs 17 crore on restatement of foreign currency loans, it added.

Sales from pharma and life sciences products and services division grew by 4.3 per cent to Rs 813 crore during the quarter, while agri and performance polymers segment registered 44.1 per cent increase of sales at Rs 169 crore.

 

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jul 27 2010 | 4:30 PM IST

Next Story